Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 8
2020 10
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines.
Pruteanu LL, Braicu C, Módos D, Jurj MA, Raduly LZ, Zănoagă O, Magdo L, Cojocneanu R, Paşca S, Moldovan C, Moldovan AI, Ţigu AB, Gurzău E, Jäntschi L, Bender A, Berindan-Neagoe I. Pruteanu LL, et al. Among authors: cojocneanu r. Int J Mol Sci. 2022 Apr 26;23(9):4784. doi: 10.3390/ijms23094784. Int J Mol Sci. 2022. PMID: 35563174 Free PMC article.
MicroRNA Dysregulation in Prostate Cancer.
Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I. Schitcu VH, et al. Among authors: cojocneanu r. Pharmgenomics Pers Med. 2022 Mar 10;15:177-193. doi: 10.2147/PGPM.S348565. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35300057 Free PMC article.
Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.
Ciocan-Cartita CA, Jurj A, Zanoaga O, Cojocneanu R, Pop LA, Moldovan A, Moldovan C, Zimta AA, Raduly L, Pop-Bica C, Buse M, Budisan L, Virag P, Irimie A, Gomes Dias SM, Berindan-Neagoe I, Braicu C. Ciocan-Cartita CA, et al. Among authors: cojocneanu r. J Exp Clin Cancer Res. 2020 Dec 17;39(1):287. doi: 10.1186/s13046-020-01789-3. J Exp Clin Cancer Res. 2020. PMID: 33327949 Free PMC article. No abstract available.
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.
Ciocan-Cartita CA, Jurj A, Zanoaga O, Cojocneanu R, Pop LA, Moldovan A, Moldovan C, Zimta AA, Raduly L, Pop-Bica C, Buse M, Budisan L, Virag P, Irimie A, Gomes Dias SM, Berindan-Neagoe I, Braicu C. Ciocan-Cartita CA, et al. Among authors: cojocneanu r. J Exp Clin Cancer Res. 2020 Nov 13;39(1):241. doi: 10.1186/s13046-020-01736-2. J Exp Clin Cancer Res. 2020. PMID: 33187552 Free PMC article.
25 results